#GenericsBulletin - Twitter Hashtag

about 1 year ago

From generics to a #biosimilars powerhouse in #MENA. In #GenericsBulletin, CEO @KalleKand shares shares how #MSPharma is localizing biologics, building 2026 portfolio. 🔗Read it full: https://t.co/YEbSVQaPAq #Localization #MarketAccess

MSPharma__'s tweet photo. From generics to a #biosimilars powerhouse in #MENA. In #GenericsBulletin, CEO @KalleKand shares shares how #MSPharma is localizing biologics, building 2026 portfolio. 🔗Read it full: https://t.co/YEbSVQaPAq
#Localization #MarketAccess https://t.co/OtuIvk4lyG

0

3

0

184

Generics bulletin @Genericbulletin

over 7 years ago

The #GenericsBulletin is an established & is recognised as the voice of the Generics & Biosimilars industries for the last 15 years. Find out more here and download a copy of the detailed flyer https://t.co/3MFnlO34sz

Genericbulletin's tweet photo. The #GenericsBulletin is an established & is recognised as the voice of the Generics & Biosimilars industries for the last 15 years. Find out more here and download a copy of the detailed flyer https://t.co/3MFnlO34sz https://t.co/mzXvFnr9Hg

0

2

1

0

Generics bulletin @Genericbulletin

over 7 years ago

With a worldwide network of experts, stay on top of global news coverage for the Generics & Biosimilars industry with new & improved #GenericsBulletin https://t.co/5sphaL1bMc

Genericbulletin's tweet photo. With a worldwide network of experts, stay on top of global news coverage for the Generics & Biosimilars industry with new & improved #GenericsBulletin https://t.co/5sphaL1bMc https://t.co/9SSxwrNlBU

0

2

0

Generics bulletin @Genericbulletin

over 7 years ago

Change happens quickly in today’s off-patent drugs landscape, so you need a platform that can keep up. Find out more about #GenericsBulletin here https://t.co/9OZWaoszhX

Genericbulletin's tweet photo. Change happens quickly in today’s off-patent drugs landscape, so you need a platform that can keep up. Find out more about #GenericsBulletin here https://t.co/9OZWaoszhX https://t.co/MseXy3hnPl

1

0

Generics bulletin @Genericbulletin

almost 8 years ago

#GenericsBulletin is now part of the @Pharma_Intell Insights Portfolio! The publication you know & trust will now deliver expanded content on Generics, Biosimilars & more 24/7. Click here: …https://t.co/AuLyDZLW8A

Genericbulletin's tweet photo. #GenericsBulletin is now part of the @Pharma_Intell Insights Portfolio! The publication you know & trust will now deliver expanded content on Generics, Biosimilars & more 24/7. Click here: …https://t.co/AuLyDZLW8A https://t.co/5Yg604GPyJ

0

2

4

0

Generics bulletin @Genericbulletin

almost 8 years ago

Grab your copy of the #GenericsBulletin today and keep on top of the global news for the generic & #biosimilar medicines industries. https://t.co/V7jQImSK07

Genericbulletin's tweet photo. Grab your copy of the #GenericsBulletin today and keep on top of the global news for the generic & #biosimilar medicines industries. https://t.co/V7jQImSK07 https://t.co/7c6vVDcE0E

0

2

0

Aidan Fry @AidanFrySTADA

almost 8 years ago

Getting ready to hand out some well deserved awards #GGB18 #GenericsBulletin #generics #biosimilars

0

2

0

Generics bulletin @Genericbulletin

about 8 years ago

@SunPharma_IR’s MD Dilip Shanghvi reveals that that the firm is “continuing to evaluate opportunities in the specialty segment to further enhance this business” but has insisted that the segment is “not a substitute for generics”. https://t.co/DCMpJTiMCy #GenericsBulletin

1

3

1

0

GGB Awards @GGB_Awards

about 8 years ago

#Teva Pharmaceuticals receives #FDA EpiPen approval.. Read the Full Story when you sign up to a free 6 week trial: https://t.co/cfPoQBIyY5 #GenericsBulletin

0

3

0

Generics bulletin @Genericbulletin

about 8 years ago

The new #GenericsBulletin is out! With a feature on #Brexit and it's implications on the supply of #medicine. https://t.co/FW0dyRp86H Subscribe today!